Biotech and Pharmaceutical
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  US Device


Market Summary

Company Profiles


Research Store

Biotech Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup


LightPath Technologies, Inc. Announces Third Quarter Fiscal 2006 Financial Results

5/8/2006 1:31:59 PM

ORLANDO, Fla., May 8 /PRNewswire-FirstCall/ -- LightPath Technologies, Inc. , a manufacturer and integrator of families of precision molded aspheric optics, GRADIUM(R) glass products, high-performance fiber- optic collimators and isolators, today announced financial results for the third quarter of fiscal 2006 and the nine months ended March 31, 2006. Our Disclosure Backlog, as defined in our Annual Report on Form 10-K for June 30, 2005, increased 40% to $3.5 million at March 31, 2006, compared to $2.5 million at the same date in the prior year. Sales for the third quarter of fiscal 2006 increased by 1%, to $3.11 million compared to the same period in fiscal 2005, and increased 5% from $2.95 million compared to the second quarter of fiscal 2006.

"As previously reported in our preliminary results, we had a healthy increase in our order board this quarter, but found ourselves unable to quickly meet the demand," commented Ken Brizel, President and Chief Executive Officer of LightPath. "Also, we had not forecasted the product mix that we received for our orders in this quarter, which included a large increase in molded optics. We planned for higher volumes and had established the capacity but were not able to execute as well as we should have to deliver to our customers."

Financial Quick Reference (In Millions, except for Three Months Nine Months per share data) Ended March 31, Ended March 31, 2006 2005 2006 2005 Unaudited Total revenues $3.11 $3.07 $8.76 $9.33 Total costs and expenses $4.23 $3.38 $11.30 $12.11 Net loss $1.12 $0.31 $2.54 $2.78 Net loss per share $0.29 $0.09 $.68 $.85 Increase\(Decrease) in cash and cash equivalents $2.11 $(0.38) $1.28 $(1.05) March 31, December 31, 2006 2005 (In Millions) Cash and cash equivalents $3.7 $1.6

Detailed comments about the third quarter of fiscal 2006: For the quarter ended March 31, 2006, we reported total revenues of $3.11 million compared to $2.95 million for the second quarter of this fiscal year, an increase of 5%. Net loss for the quarter was $1.12 million, or $0.29 per share. Our gross margin percentage in the third quarter of fiscal 2006 compared to second quarter 2006 was lower at 10%. The total manufacturing cost of $2.79 million was $0.53 million higher in the third quarter of fiscal 2006 than it was in the same period of the prior fiscal year. Because of significant shift in production mix during the third quarter of fiscal 2006 we spent $0.20 million in overtime costs to increase production volumes for molded optics. We also incurred about $0.15 million of start-up costs for our subsidiary operating in Jiading, Peoples Republic of China. We also experienced reduced sales of collimators and isolators which impacted our cost by another of $0.18 million due to lower utilization and incurred an increase in SG&A expense of $0.35 million due to inflation of salaries, rent and property taxes and start- up salaries for employees of our subsidiary in China. Operating cash use in the quarter was also high at $1.42 million. In addition, working capital requirements increased by $0.54 million due primarily to an increase in accounts receivable caused by 51% of the quarter's shipments being made in March and payments to vendors to secure supplies for shipments. We estimate that our one time or non-recurring cost impacts were approximately $0.35 million. As compared to the second quarter of fiscal 2006, our costs and expenses were up $0.62 million, however, adjusting for the one time or non- recurring cost impacts of start-up costs of our subsidiary in China, product mix changes and overtime costs incurred in the third quarter, costs and expenses in this quarter would have been nearly the same as in the second quarter with approximately $0.15 million more in sales.

Detailed comments about the first nine months of fiscal 2006: For the nine month period ended March 31, 2006, the Company reported total revenues of $8.76 million compared to $9.33 million for the same period in fiscal 2005, a decrease of 6%. Net loss for the first nine months of fiscal 2006 was $2.54 million, or $0.68 per share, an improvement over the loss in last year's comparable nine-month period of $2.78 million, or $0.85 per share. Gross margin decreased to 18% during this period from 21% from the same period in fiscal 2005, due to start-up costs of $0.25 million we incurred in connection with our subsidiary in China. We incurred an increase in SG&A expense of $0.096 million due to inflation of salaries, rent and property taxes and start-up salaries for our employees of our subsidiary in China. New product development expenses increased from $0.75 million in the first nine months of fiscal 2005 to $0.76 million in the first nine months of fiscal year 2006. The increase was due to slightly higher personnel costs offset by lower consumable material and outside services costs.

Cash Status: For the quarter ended March 31, 2006, cash increased this period by $2.11 million compared to a decrease of $0.38 million in the same period of the prior fiscal year. During the quarter ending March 31, 2006 we engaged in a private placement of our common stock resulting in net proceeds of $3.5 million after payment of placement agent fees and commission. While we typically have a high used of cash in our third quarter due to seasonal factors, operating cash use in the quarter ended March 31, 2006, was unusually high at $1.42 million due primarily to profit impact of about $0.88 million and working capital requirements of $0.54 million. However, if adjusted for the start-up costs of our subsidiary in China, overtime costs incurred in the third quarter and a high level of accounts receivable for the period due to higher than usual March shipments, cash usage for the quarter would have been lower by approximately $0.85 million.

Comments: Ken Brizel, President and CEO of LightPath, stated, "This has been a disappointing quarter. We lost momentum in isolators and collimators. Also, while we have experienced great demand for our molded optic products, we were unable to fill all the orders we should have in the quarter. Our objective is to be able to meet our revenue targets even if our production mix resulting from orders received changes significantly. Our backlog continues to strengthen and it appears as if it will continue to increase. We anticipate that with the implementation of early warning financial metrics by our new Chief Financial Officer, an increase in production by our subsidiary in China, and the high level of morale and energy of the Orlando work force, I am confident that the fourth quarter of the fiscal year will get us back on track with respect to the trends that started during the second quarter of fiscal 2006."

Additional information concerning LightPath Technologies, Inc. and our products can be found at our web site at .

Webcast Details:

LightPath plans to hold an audio webcast at 3:00 p.m. EDT on May 8, 2006 to discuss details regarding its performance for the third quarter and first nine-month period of fiscal 2006. The session may be accessed at . A transcript archive of the webcast will be available for viewing or download on our web site shortly after the call is concluded.

LightPath manufactures optical products, including precision molded aspheric optics, GRADIUM(R) glass products, proprietary collimator assemblies, laser components utilizing proprietary automation technology, higher-level assemblies and packing solutions. LightPath has a strong patent portfolio that has been granted or licensed to us in these fields. LightPath common stock trades on the Nasdaq Capital Market under the symbol "LPTH." Investors are encouraged to go to LightPath's web site for additional financial information.

Contact: Dorothy Cipolla, CFO LightPath Technologies, Inc. (407) 382-4003 Internet:

This news release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This information may involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, factors detailed by LightPath Technologies, Inc. in its public filings with the Securities and Exchange Commission.

LIGHTPATH TECHNOLOGIES, INC. Condensed Consolidated Balance Sheets (unaudited) March 31, June 30, Assets 2006 2005 Current assets: Cash and cash equivalents $3,737,621 2,462,540 Trade accounts receivable, net of allowance of $85,800 and $26,500, respectively 2,242,311 1,456,612 Inventories 1,566,786 1,741,494 Prepaid expenses and other assets 95,155 222,430 Total current assets 7,641,873 5,883,075 Property and equipment - net 1,253,787 1,335,612 Intangible assets - net 273,690 325,008 Other assets 73,771 65,214 Total assets $9,243,121 7,608,909 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $925,306 865,960 Accrued liabilities 455,767 387,617 Accrued payroll and benefits 376,576 358,606 Accrued severance and exit costs Notes Payable, current portion 271,199 12,479 Total current liabilities 2,028,848 1,624,662 Capital lease obligation, excluding current portion 43,681 54,193 Stockholders' equity: Common stock: Class A, $.01 par value, voting; 34,500,000 shares authorized; 4,426,268 shares issued and outstanding at March 31, 2006 and June 30, 2005, respectively 44,263 36,956 Additional paid-in capital 195,980,842 192,426,330 Accumulated deficit (188,854,513) (186,311,002) Unearned compensation -- (222,230) Total stockholders' equity 7,170,592 5,930,054 Total liabilities and stockholders' equity $9,243,121 7,608,909 LIGHTPATH TECHNOLOGIES, INC. Condensed Consolidated Statement of Operations (unaudited) Three months ended Nine months ended March 31, March 31, 2006 2005 2006 2005 Product sales, net $3,106,674 $3,065,310 $8,762,956 $9,329,972 Cost of sales 2,798,070 2,268,520 7,158,826 7,392,693 Gross margin 308,604 796,790 1,604,130 1,937,279 Operating expenses: Selling, general and administrative 1,183,390 830,275 3,386,073 3,290,158 New product development 261,858 224,633 761,681 753,860 Amortization of intangibles 8,216 38,217 51,318 542,672 Total costs and expenses 1,453,464 1,093,125 4,199,072 4,586,690 Operating loss (1,144,860) (296,335) (2,594,942) (2,649,411) Other income (expense) Loss on settlement of litigation -- -- -- (70,000) Gain on sales of assets -- (13,042) 9,134 10,499 Investment and other income (expense), net 27,115 3,394 42,297 (72,198) Net loss $(1,117,745) $(305,983) $(2,543,511) $(2,781,110) Loss per share (basic and diluted) $(0.29) $(0.09) $(0.68) $(0.85) Number of shares used in per share calculation 3,826,560 3,311,984 3,739,283 3,287,587 LIGHTPATH TECHNOLOGIES AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Nine Months Ended March 31, 2006 2005 Cash flows due to operating activities Net loss $(2,543,511) $(2,781,110) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 637,853 1,342,720 Loss on sale of equipment (9,134) (10,499) Stock based compensation 200,684 389,292 Provision for doubtful accounts receivable 90,200 (46,455) Changes in operating assets and liabilities: Trade Receivables (875,899) 68,462 Inventories 174,708 (270,404) Prepaid expenses and other assets 118,718 415,131 Accounts Payable and accrued expenses 145,466 (216,875) Net cash used in operating activities (2,060,916) (1,109,738) Cash flows due to investing activities Property and equipment additions (505,491) (51,243) Proceeds from sale of assets 9,915 112,627 Net cash used in investing activities (495,576) 61,384 Cash flows due to financing activities Proceeds from exercise of stock options 815 521 Proceeds from sale of common stock 3,582,550 -- Borrowings on capital leases 248,208 -- Payments on capital lease obligation -- (5,459) Net cash provided by (used in) financing activities 3,831,573 (4,938) Increase (Decrease) in cash and cash equivalents 1,275,081 (1,053,292) Cash and cash equivalents, beginning of period 2,462,540 2,531,029 Cash and cash equivalents, end of period $3,737,621 $1,477,737 Supplimental disclosure of cash flow information: Non-cash financing activity: Capital lease obligation -- 75,000 Interest paid $12,739 --

LightPath Technologies, Inc.

CONTACT: Dorothy Cipolla, CFO, LightPath Technologies, Inc.,+1-407-382-4003

Read at